AzTrials
AzTrials

FallAL-STEADINCT07531641

From Screening to Safety: Implementing the AL-STEADI Initiative in Assisted Living Communities

A study testing AL-STEADI in people with Fall and Fall Injury Prevention, run by Brown University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this trial is to test the real-world efficacy of AL-STEADI, a fall prevention program, in participating assisted living centers. The investigators will randomly assign residents from participating assisted living centers who screen at-risk of falling to either existing fall monitoring protocols or the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Fall, Fall Injury Prevention, Fall Prevention
What is being tested?
AL-STEADI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
700 participants
Where
No sites listed yet
Study dates
Jun 2027to Sep 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Living in participating assisted living communities

Who cannot join

  • Not living in participating assisted living communities

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Ellen McCreedy, PhD, MPH contact

(401) 863-7345

ellen_mccreedy@brown.edu

About this study

The goal of this trial is to test the real-world efficacy of AL-STEADI, a fall prevention program, in participating assisted living centers. The investigators will randomly assign residents from participating assisted living centers who screen at-risk of falling to either existing fall monitoring protocols or the enhanced AL-STEADI fall prevention program. The investigators will evaluate the effect of AL-STEADI on the rate of falls over 12 months. The investigators will also closely monitor implementation fidelity in these participating assisted living centers.

Being tested
AL-STEADI, Usual Care Group
Keywords
assisted living, fall prevention, STEADI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AL-STEADIBehavioural

    STEADI is an evidence-based falls prevention program developed by the CDC and tested in several community-based settings. STEADI involves universal fall screening, followed by personalized assessments and tailored interventions. Common, potentially modifiable causes of falls evaluated in STEADI include medication interactions or side effects, environmental hazards (e.g., floor rugs, thresholds), untreated visual impairment, low vitamin D, ill-fitting footwear, or low blood pressure. AL-STEADI is a modified version of STEADI for assisted living.

  • Usual Care GroupBehavioural

    Typical fall prevention practices, including increased monitoring by assisted living staff

Study groups in NCT07531641
Study groupRoleWhat they receive
AL-STEADIExperimentalNot described
Receives: Behavioral: AL-STEADI
Existing fall monitoring protocolsActive comparatorNot described
Receives: Behavioral: Usual Care Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fall rate

    Number of staff documented falls per 12 non-censored person-months, among individuals who screen at-risk for falls

    Measured: 12 person-months

Secondary outcomes (9)
  1. Proportion of fall-risk residents with any fall

    Proportion of residents with any staff documented fall during follow-up, among individuals who screen at-risk for falls

    Measured: 12 person-months

  2. Injurious fall rate among fall-risk residents

    Number of staff documented injurious falls per 12 non-censored person-months, among individuals who screen at-risk for falls

    Measured: 12 person-months

  3. Proportion of fall-risk residents with any injurious fall

    Proportion of residents with any staff documented injurious fall during follow-up, among individuals who screen at-risk for falls

    Measured: 12 person-months

  4. Hospital transfer rate among fall-risk residents

    Number of hospital transfers per 12 non-censored person-months, among individuals who screen at-risk for falls

    Measured: 12 person-months

  5. Proportion of fall-risk residents with any hospital transfer

    Proportion of residents with any hospital transfers during follow-up, among individuals who screen at-risk for falls

    Measured: 12 person-months

  6. Hospitalization rate among fall-risk residents

    Number of in-patient hospitalizations per 12 non-censored person-months, among individuals who screen at-risk for falls

    Measured: 12 person-months

  7. Proportion of fall-risk residents with any hospitalization

    Proportion of residents with any in-patient hospitalization during follow-up, among individuals who screen at-risk for falls

    Measured: 12 person-months

  8. Skilled nursing stay rate among fall-risk residents

    Number of skilled nursing stays per 12 non-censored person-months, among individuals who screen at-risk for falls

    Measured: 12 person-months

  9. Proportion of fall-risk residents with any skilled nursing stay

    Proportion of residents with any skilled nursing stay during follow-up, among individuals who screen at-risk for falls

    Measured: 12 person-months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2026
  2. Study startJun 2027 (estimated)
  3. Primary completionJun 2029 (estimated)
  4. Study completionSep 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
700 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07531641
Sponsor's protocol ID
U01CE003720
Other IDs
U01CE003720
Acronym
AL-STEADI
Status last verified
Apr 2026
First submitted
9 Apr 2026
Last updated
15 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Resident-level, electronic medical record data will be protected by Data Use Agreements and cannot be shared publicly. Summary tables may be made available; small cell restrictions and other measures to prevent re-identification would apply

Questions about this trial

What is this clinical trial studying?

A study testing AL-STEADI in people with Fall and Fall Injury Prevention, run by Brown University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 15 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Ellen McCreedy, PhD, MPH ((401) 863-7345, ellen_mccreedy@brown.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fall rate (time frame: 12 person-months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in